Epidarex Capital News and Activities

Acquisition, funding and merger involving Epidarex Capital.

• Epidarex Capital has just announced a $145 Million fundraising (posted on January 27 2026).
• Epidarex Capital has just announced a $50 Million fundraising (posted on January 22 2026).

View the org chart displaying its 7 main executives

Most searched biographies at Epidarex Capital

• Matthew Miessau, Principal
• Zach Hamelinck, Director, Investor Relations
• Elizabeth Roper, General Partner

Create your alert
to follow the executive moves at Epidarex Capital.

Epidarex Capital has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Epidarex Capital

Social media about Epidarex Capital

• Epidarex Capital on Wikipedia, Google News & Yahoo Finance
• Epidarex Capital on LinkedIn, X (Twitter) & YouTube